TABLE 3.
Logistic regression models estimating the effect of CSA on clinical outcomes
| % in No CSA | % in CSA | OR (95% CI) | Adjusted a OR (95% CI) | |
|---|---|---|---|---|
| Inpatient admissions (yes) | 51.1% | 67.0% | 1.95 (1.64–2.32) | 1.92 (1.61–2.30) |
| Above the median inpatient days p/year (10 days) | 50.1% | 56.9% | 1.31 (1.07–1.62) | 1.28 (1.04–1.57) |
| Antipsychotic medication (yes) | 89.5% | 95.5% | 2.48 (1.68–3.65) | 2.48 (1.65–3.66) |
| Above the median maximum recommended daily dose (75%) | 47.6% | 60.9% | 1.72 (1.44–2.04) | 1.70 (1.42–2.01) |
a
Adjusted for sex, age at first presentation and ethnicity.